BiotechTube
Home/Allinaire Therapeutics/Matthias Clauss, PhD
MC

Matthias Clauss, PhD

Scientific Co-founder

Allinaire Therapeutics

Therapeutic Areas

Pulmonary Arterial HypertensionCardiopulmonary Diseases

Allinaire Therapeutics Pipeline

DrugIndicationPhase
Anti-EMAP II monoclonal antibodyPulmonary Arterial Hypertension (PAH)Pre-clinical

Leadership Team at Allinaire Therapeutics

DW
Douglas W.P. Hay, PhD
CEO and CSO
CP
Christa Pawlowski, PhD
COO
IP
Irina Petrache, MD
Scientific Co-founder
SJ
Satish Jindal, PhD
Chairman of the Board, Partner at Advent Life Sciences
View full Allinaire Therapeutics profile